Paper39340558
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.
Zeyen T and 17 others. J Cancer Res Clin Oncol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection. Papers, record 39340558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39340558
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| COVID-19 | Major topic |
| Glioblastoma | Major topic |
| Magnetic Resonance Imaging | Major topic |
| SARS-CoV-2 | Major topic |
| Humans | |
| Tumor Microenvironment |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28382534 | Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. | J Neurooncol | 2017 | https://conductscience.org/library/papers/28382534 | PubMed |
| 2 | 38720342 | Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/38720342 | PubMed |
| 3 | 39006516 | Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study. | Neurooncol Pract | 2024 | https://conductscience.org/library/papers/39006516 | PubMed |
| 4 | 36079151 | Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies. | J Clin Med | 2022 | https://conductscience.org/library/papers/36079151 | PubMed |
| 5 | 36058935 | In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants. | Acta Neuropathol Commun | 2022 | https://conductscience.org/library/papers/36058935 | PubMed |
| 6 | 36790010 | Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know. | J Neurosurg | 2023 | https://conductscience.org/library/papers/36790010 | PubMed |
| 7 | 36797335 | Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations. | Sci Rep | 2023 | https://conductscience.org/library/papers/36797335 | PubMed |
| 8 | 27515827 | Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma. | Neuro Oncol | 2016 | https://conductscience.org/library/papers/27515827 | PubMed |
| 9 | 29943666 | Recurrent Glioblastoma Treated with Recombinant Poliovirus. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29943666 | PubMed |
| 10 | 35864254 | Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. | Nat Med | 2022 | https://conductscience.org/library/papers/35864254 | PubMed |
| 11 | 33838625 | Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33838625 | PubMed |
| 12 | 33307200 | Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review: Part 1 - Molecular, morphological and clinical features. | Crit Rev Oncol Hematol | 2021 | https://conductscience.org/library/papers/33307200 | PubMed |
| 13 | 34174183 | Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. | Immunity | 2021 | https://conductscience.org/library/papers/34174183 | PubMed |
| 14 | 37224228 | Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37224228 | PubMed |
| 15 | 38279060 | Surgical site infections after glioblastoma surgery: boon or bane? | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38279060 | PubMed |
| 16 | 27286796 | Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain. | Neuro Oncol | 2016 | https://conductscience.org/library/papers/27286796 | PubMed |
| 17 | 37238200 | Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37238200 | PubMed |
| 18 | 28862482 | Pseudoprogression after glioma therapy: an update. | Expert Rev Neurother | 2017 | https://conductscience.org/library/papers/28862482 | PubMed |
| 19 | 37853118 | Clinical trial links oncolytic immunoactivation to survival in glioblastoma. | Nature | 2023 | https://conductscience.org/library/papers/37853118 | PubMed |
| 20 | 27935360 | The effect of postoperative infection on survival in patients with glioblastoma. | J Neurosurg | 2017 | https://conductscience.org/library/papers/27935360 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41498242 | COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms. | Oncotarget | 2026 | https://conductscience.org/library/papers/41498242 | PubMed |
| 40983970 | Primary leptomeningeal histiocytic lymphoproliferative disorder associated with SARS-CoV-2 brain infection in k18-hACE2 mouse: a case report. | Lab Anim Res | 2025 | https://conductscience.org/library/papers/40983970 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39340558
GET https://conductscience.org/api/papers/v1/39340558/references?page=2